Skip to content
Lower risk Drug recall · FDA · Published June 24, 2022

Noven Daytrana patches recalled due to ripping and adhesive issues

Noven Pharmaceuticals recalls Daytrana patches after customer complaints about ripping and adhesive transfer problems. This medication, used for ADHD, requires prescription and has a specific delivery system.

🇺🇸 FDA recall #D-1169-2022DrugNoven ›
Take action

Contact the company

Recalling firmNoven Pharmaceuticals Inc11960 Sw 144th St · Miami, FL 33186-6109
✎ GovInfoNow plain-language explainer

Noven Pharmaceuticals is recalling Daytrana (methylphenidate transdermal patches) because customers reported issues with the patches ripping and adhesive transfer. This could lead to inconsistent medication delivery, which may affect treatment effectiveness. Read more at govinfonow.com/recall/34509-noven-daytrana-patches-recalled-due-to-ripping-and-adhesive-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/34509-noven-daytrana-patches-recalled-due-to-ripping-and-adhesive-issues · Updated September 23, 2026 · FDA enforcement record: FDA #D-1169-2022

Cite this page

“Noven Daytrana patches recalled due to ripping and adhesive issues.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34509-noven-daytrana-patches-recalled-due-to-ripping-and-adhesive-issues. Based on FDA recall #D-1169-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1169-2022%22&limit=1).

The FDA announced on June 24, 2022, that Noven Pharmaceuticals Inc is voluntarily recalling Daytrana (methylphenidate transdermal system) due to a defective delivery system. The recall affects 8,559 cartons distributed nationwide.

How to tell if you have it

  • Brand: Noven
  • Product: Daytrana (methylphenidate transdermal system)
  • Dosage: Delivers 10 mg over 9 hours (1.1 mg/hr)
  • Quantity: Contains 30 Patches
  • NDC: 68968-5552-3
  • Lot Code: 91272
  • Expiration Date: Exp. 12/22

The hazard

According to the FDA, customer complaints were received regarding ripping patches and tight release/adhesive transfer issues with the product.

Context

GovInfoNow's records show Noven Pharmaceuticals Inc has had 24 other recalls on record since July 5, 2011. Other recent recalls of similar products include Noven Xelstrym 13.5mg Transdermal System Recall (Oct. 31, 2024), Noven Daytrana 10mg Transdermal System Recall (March 10, 2023), and Noven Daytrana patches recalled due to defective adhesive delivery (Nov. 16, 2022). Other recent recalls of similar products include Blossom Pharmaceuticals Dynagel Wound Hydrogel Recall (Oct. 31, 2025), Wells Pharma Fentanyl Citrate Injectable Solution Recall (April 1, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (Nov. 17, 2025).

How to tell if you have this one

Check for Daytrana patches with NDC 68968-5552-3 and expiration date 12/22. The product was manufactured by Noven Pharmaceuticals Inc in Miami, FL.

  • Brand
    Noven
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number 68968-5552-3 and expiration date 12/22 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 12 days after the firm started it.

1. Firm started the recall: Jun 24, 202212. FDA classified it Class II: Jun 29, 202223. Published in FDA’s Enforcement Report: Jul 6, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1169-2022 (June 24, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1169-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA